JI Jianhua, CHENG Jie. Efficiency of iguratimod combined with hydroxychloroquinein treating patients with Sjogren's syndrome and its influence on expression of surface molecules of B cells[J]. Journal of Clinical Medicine in Practice, 2019, 23(13): 14-17. DOI: 10.7619/jcmp.201913004
Citation: JI Jianhua, CHENG Jie. Efficiency of iguratimod combined with hydroxychloroquinein treating patients with Sjogren's syndrome and its influence on expression of surface molecules of B cells[J]. Journal of Clinical Medicine in Practice, 2019, 23(13): 14-17. DOI: 10.7619/jcmp.201913004

Efficiency of iguratimod combined with hydroxychloroquinein treating patients with Sjogren's syndrome and its influence on expression of surface molecules of B cells

More Information
  • Received Date: May 14, 2019
  • Accepted Date: June 21, 2019
  • Available Online: February 23, 2021
  • Published Date: July 14, 2019
  •   Objective  To analyze the clinical efficacy of hydroxychloroquine combined with iguratimod in the treatment of patients with Sjogren's syndrome and its effect on the expression of surface molecules of B cells.
      Methods  Totally 82 patients with Sjogren′s syndrome were divided into two groups, with 41 cases in each group. The control group was treated with hydroxychloroquine, while the study group was treated with hydroxychloroquine and iguratimod. The efficiency and expression of surface molecules of B cells were compared between the two groups.
      Results  The total effective rate of the study group was 90.24%, which was significantly higher than 68.29% of the control group (P < 0.05). The levels of immunoglobulin G, rheumatoid factors erythrocyte sedimentation rate and in the study group were significantly lower than those in the control group, and the platelet count was significantly higher than that in the control group (P < 0.05). The expression rates of human B-cell activating factor receptor (BAFF-R), CD38-IgD, self-perception score of Sjogren′s syndrome (ESSPRI) and disease activity of Sjogren′s syndrome (ESSDAI) score in the study group were significantly lower than those in the control group, and the value of Schirmer′s Ⅰ Test(SⅠT) and salivary flow rate were significantly higher than those in the control group (P < 0.05).
      Conclusion  Iguratimod combined with hydroxychloroquine is effective in the treatment of patients with Sjogren′s syndrome, which can inhibit the activity of B cells, prevent the accumulation of immunoglobulin and improve the symptoms of patients.
  • [1]
    程晓静, 张葵, 符向辉, 等. B细胞刺激因子及其受体在干燥综合征发病机制中的作用进展[J]. 中国医药导报, 2017, 14(3): 47-51. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201703013.htm
    [2]
    李连菊, 王京旭, 李晓丽. 艾拉莫德联合甲氨蝶呤治疗早期类风湿关节炎临床研究[J]. 中国药业, 2019, 28(7): 63-65. doi: 10.3969/j.issn.1006-4931.2019.07.020
    [3]
    余莹莹, 石天, 刘俊龙, 等. 重组人细胞白介素2治疗类风湿关节炎合并干燥综合征的临床效果及对血清B淋巴细胞刺激因子水平的影响[J]. 国际免疫学杂志, 2018, 41(5): 504-508. doi: 10.3760/cma.j.issn.1673-4394.2018.05.005
    [4]
    邵培培, 马丛, 王北, 等. 养阴益气合剂联合硫酸羟氯喹治疗气阴两虚型干燥综合征36例临床观察[J]. 世界中医药, 2018, 13(3): 616-619. doi: 10.3969/j.issn.1673-7202.2018.03.017
    [5]
    朱幼鸣, 张克珍, 杨立志, 等. 七味白术散合生脉散对干燥综合征患者血清IgA、IgM、IgG和T淋巴细胞亚群的影响[J]. 现代中西医结合杂志, 2017, 26(21): 2339-2341. doi: 10.3969/j.issn.1008-8849.2017.21.020
    [6]
    霍晓萌. 活血解毒方联合硫酸羟氯喹治疗干燥综合征疗效及对Th17/Treg免疫失衡的影响[J]. 现代中西医结合杂志, 2018, 27(12): 1331-1333. doi: 10.3969/j.issn.1008-8849.2018.12.022
    [7]
    史云晖, 柳洋, 韦尼, 等. 活血解毒方对干燥综合征小鼠干扰素-γ、B细胞活化因子及其受体的干预作用研究[J]. 环球中医药, 2016, 9(1): 20-24. doi: 10.3969/j.issn.1674-1749.2016.01.005
    [8]
    吴晓畅, 王领, 张娜, 等. 艾拉莫德对干燥综合征模型小鼠的影响[J]. 实用医学杂志, 2018, 34(22): 3700-3704. doi: 10.3969/j.issn.1006-5725.2018.22.009
    [9]
    张玉兰, 李琴, 王福祖, 等. 自拟生津汤联合艾拉莫德对原发性干燥综合征患者ACL及RF水平的影响[J]. 现代生物医学进展, 2017, 17(17): 3377-3380. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX201717046.htm
    [10]
    曹丽娜, 殷寒秋, 李朝虹, 等. 艾拉莫德治疗老年类风湿关节炎的临床效果及对骨代谢的影响[J]. 中国老年学杂志, 2018, 38(22): 5500-5502. doi: 10.3969/j.issn.1005-9202.2018.22.050
  • Cited by

    Periodical cited type(5)

    1. 汤思,陈学杰. 直接抗人球蛋白试验阳性分型与输血疗效的相关性. 吉林医学. 2024(02): 295-297 .
    2. 杨占甲,李丽娟,宋银森. 多发性骨髓瘤患者红细胞输注效果的影响因素探讨. 中国实用医刊. 2024(13): 66-69 .
    3. 梁冬香,钟昌瑞,傅春花,邱启东. 直接抗人球蛋白试验凝集强度的结果分析及临床意义. 临床血液学杂志. 2024(12): 905-908 .
    4. 闻才李,张慧,杨吉岳,孙一心,程晓文. 直接抗人球蛋白试验阳性患者298例的病因回顾性分析. 医药论坛杂志. 2022(08): 72-74+78 .
    5. 胡泽斌,孙彬裕,孙晶,王布强,于婷. 抗人球蛋白检测卡行业标准的研究. 中国医药生物技术. 2022(05): 449-452 .

    Other cited types(0)

Catalog

    Article views (308) PDF downloads (9) Cited by(5)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return